.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
Chinese Patent Office
Queensland Health
Cerilliant
Colorcon
Fuji
Baxter
US Department of Justice
Dow
McKesson

Generated: November 19, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 087197

« Back to Dashboard
NDA 087197 describes SULFASALAZINE, which is a drug marketed by Watson Labs, Vintage Pharms, Superpharm, Sandoz, Sun Pharm Inds, and Heritage Pharms Inc, and is included in ten NDAs. It is available from nine suppliers. Additional details are available on the SULFASALAZINE profile page.

The generic ingredient in SULFASALAZINE is sulfasalazine. There are ten drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the sulfasalazine profile page.

Summary for 087197

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Therapeutic Class:Inflammatory Bowel Disease Agents
Formulation / Manufacturing:see details

Pharmacology for NDA: 087197

Ingredient-typeAminosalicylic Acids

Suppliers and Packaging for NDA: 087197

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
SULFASALAZINE
sulfasalazine
TABLET;ORAL 087197 ANDA Preferred Pharmaceuticals, Inc 68788-9021 68788-9021-1 120 TABLET in 1 BOTTLE, DISPENSING (68788-9021-1)
SULFASALAZINE
sulfasalazine
TABLET;ORAL 087197 ANDA Preferred Pharmaceuticals, Inc 68788-9021 68788-9021-3 30 TABLET in 1 BOTTLE, DISPENSING (68788-9021-3)

Summary for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength500MG
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Federal Trade Commission
US Army
US Department of Justice
Fuji
Novartis
Queensland Health
Colorcon
Boehringer Ingelheim
AstraZeneca
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot